St. Jude Researchers Discover 156 New Potential Targets for CAR T-cell Immunotherapy Against Various Cancers, Validating COL11A1 and Launching SCE-Miner Portal
by The challenge of targeting cancer cells specifically while leaving healthy cells untouched is a significant hurdle in cancer therapy, particularly for chimeric antigen receptor (CAR) …